2011
DOI: 10.1016/j.biopsych.2011.06.033
|View full text |Cite
|
Sign up to set email alerts
|

Response Perseveration in Stimulant Dependence Is Associated with Striatal Dysfunction and Can Be Ameliorated by a D2/3 Receptor Agonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

20
141
6
2

Year Published

2011
2011
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 120 publications
(169 citation statements)
references
References 56 publications
20
141
6
2
Order By: Relevance
“…Ropinirole acted as, albeit a weak, reinforcer in nonhuman primates (Freeman, Heal, McCreary, & Woolverton, 2012), which partly supports clinical data, suggesting that ropinirole marginally reduced craving in humans (Meini et al, 2012) and reduced the subjective intensity for the "cocaine rush" (Maremmani et al, 2011). Treatment with another dopamine D 2 agonist, pramipexole, caused perseverated responding in a reversal learning task, which was associated with stimulant dependence, rather than compulsive measures, suggesting additional efficacy for the potential treatment of SUD (Ersche et al, 2011). Together, these data support the dopamine replacement hypotheses, suggesting that clinically approved dopaminomimetic compounds might have clinical utility.…”
Section: L-dopasupporting
confidence: 56%
“…Ropinirole acted as, albeit a weak, reinforcer in nonhuman primates (Freeman, Heal, McCreary, & Woolverton, 2012), which partly supports clinical data, suggesting that ropinirole marginally reduced craving in humans (Meini et al, 2012) and reduced the subjective intensity for the "cocaine rush" (Maremmani et al, 2011). Treatment with another dopamine D 2 agonist, pramipexole, caused perseverated responding in a reversal learning task, which was associated with stimulant dependence, rather than compulsive measures, suggesting additional efficacy for the potential treatment of SUD (Ersche et al, 2011). Together, these data support the dopamine replacement hypotheses, suggesting that clinically approved dopaminomimetic compounds might have clinical utility.…”
Section: L-dopasupporting
confidence: 56%
“…Deficits in cognitive flexibility are known in patients experiencing addiction (Bechara and Damasio, 2002;Garavan and Stout, 2005;Ersche et al, 2011;Goldstein and Volkow, 2011). In line with this, we demonstrate that alcohol-dependent patients show diminished behavioral adaptation in a dynamic environment.…”
Section: Disrupted Behavioral Adaptation In Addictionmentioning
confidence: 99%
“…Groups differed in terms of general cognition, smoking status, and gray matter density even though our results were robust when adjusting for these variables. Crosssectional studies in at-risk populations (Ersche et al, 2010;Reiter et al, 2016), and longitudinal designs are warranted to track the influence of dysfunctional behavioral control systems across different stages in the development of addiction. It is to be noted that our model was not able to capture one specific aspect of the observed choice behavior, namely the group ϫ phase interaction on correct choices due to particularly reduced performance in the middle and last phase.…”
Section: Neurochemical Considerationsmentioning
confidence: 99%
“…Thus, intact episodic memory may be required to support the cognitive effort required in psychotherapies for CD. Whereas functional disturbances in habit learning systems are reported in substance use disorders (SUD) (Chiu et al, 2008;Ersche et al, 2011;Ghahremani et al, 2011;Park et al, 2010;Rose et al, 2012), the functioning of neural systems for episodic memory have not been assessed in CD. Additional disturbances in these systems would further support the learning model of human addiction, point to a putative mechanism of action for psychotherapies for CD, and offer additional targets for treatment development.…”
Section: Introductionmentioning
confidence: 99%